ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2015

Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus.

Seitaro Omoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.